Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Aki Inoue"'
Publikováno v:
Practica Oto-Rhino-Laryngologica. 115:653-657
Autor:
Tomoaki Nakada, Shinichi Nishimura, Mari Kawashima, Mariko Koike, Yasutaka Kojima, Aki Inoue, Yuko Hata, Taeko Okuno
Publikováno v:
Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo). 124:1594-1601
Publikováno v:
Equilibrium Research. 80:41-49
Autor:
Yuya Kawakami, Yosiki Yamagishi, Ryota Komiya, Aki Inoue, Yoshitada Masuda, Ryosuke Irie, Joji Ota
Publikováno v:
Japanese Journal of Radiological Technology. 76:1080-1085
Autor:
Ayumi Mori, Sayaka Omura, Akiko Ito, Aki Inoue, Mineko Oka, Muneo Nakaya, Teruhiko Fuchigami, Wataru Kida, Yasuhiro Inayoshi
Publikováno v:
Auris Nasus Larynx. 44:111-115
Objective Substernal goiters are classified as primary or secondary intrathoracic goiters. Here, we report the diagnosis, symptoms, treatment, and postoperative complications of 44 substernal goiters (2 primary mediastinal goiter and 42 secondary med
Publikováno v:
Otologyneurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 40(3)
Objective To evaluate the progression of peripheral vestibular dysfunction in patients with an A-to-G point mutation at nucleotide pair 3243 in mitochondrial DNA (A3243G mutation). Study design Retrospective patient series. Setting Tertiary referral
Publikováno v:
Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology). 55:21-26
Autor:
Yoshinori Maeda, Yuji Morimoto, Shigeto Fukushima, Nobuhiro Nishiyama, Kozo Miyazaki, Akihiro Kishimura, Kazuko Toh, Aki Inoue, Kazunori Kataoka, Takahiro Nomoto, Michiaki Kumagai, Yu Matsumoto, Peng Mi
Publikováno v:
Biomaterials Science. 4:826-838
Photodynamic therapy (PDT) is a promising treatment modality for malignant tumors in a light-selective manner. To improve the PDT efficacy, numerous kinds of nanocarriers have been developed to deliver photosensitizers (PSs) selectively into the tumo
Autor:
Aki Inoue, Shinichi Iwasaki
Publikováno v:
Otology & Neurotology. 40:1260-1261
Publikováno v:
Molecular and Clinical Oncology. 3:601-606
The aim of this study was to evaluate the oncological efficacy of tyrosine kinase inhibitors (TKIs) as first-line molecular-targeted therapy for Japanese patients with metastatic renal cell carcinoma (mRCC) in a routine clinical setting. This study i